Cargando…
Bone marrow biopsy can be omitted in the diagnostic workup of CNS lymphoma of DLBCL origin: a population-based retrospective study in the PET-CT era
Currently, bone marrow (BM) biopsy (BMB) is recommended in the initial staging of patients with the presumed primary central nervous system (CNS) lymphoma (PCNSL). However, the added value of BMB in the era of positron emission tomography (PET-CT) has been challenged in other lymphoma subtypes. We a...
Autores principales: | Jelicic, Jelena, Hansen, Dennis Lund, Carlsen, Sarah Sand, Thorsgaard, Michael, Hersby, Ditte Stampe, Kannik, Karina, Munksgaard, Amalie Sofie Eilsø, Larsen, Thomas Stauffer, Juul-Jensen, Karen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10261253/ https://www.ncbi.nlm.nih.gov/pubmed/37246974 http://dx.doi.org/10.1007/s00277-023-05282-7 |
Ejemplares similares
-
CAR T-cell therapy for secondary CNS DLBCL
por: Ahmed, Gulrayz, et al.
Publicado: (2021) -
CNS Involvement of DLBCL Presenting with an Unusual Non-Enhancing Infiltrative Mass
por: Hsueh, Fu-Sheng, et al.
Publicado: (2023) -
Omitted Acknowledgment
Publicado: (2020) -
Reference Omitted
Publicado: (2023) -
Leptomeningeal relapse in primary cutaneous DLBCL: Implications for a prophylactic CNS therapy
por: Sundriyal, Deepak, et al.
Publicado: (2020)